Integrated analysis of mRNA and microRNA expression profiles reveals differential transcriptome signature in

Xiuli Shao1, Xiaolin Zhang1, Lei Yang2

  • 1Department of Pharmaceutical Toxicology, School of Pharmacy, China Medical University, Shenyang, China.

Epigenetics
|October 5, 2020
PubMed

Insights

This study identifies miR-542-3p and its target CILP as key regulators in heart failure, potentially offering new diagnostic and therapeutic targets for ischemic and dilated cardiomyopathy.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Genomics

Background:

  • Cardiac remodelling is a hallmark of heart failure (HF), impacting conditions like ischemic cardiomyopathy (ICM) and dilated cardiomyopathy (DCM).
  • MicroRNAs (miRNAs) and messenger RNAs (mRNAs) are implicated as diagnostic and therapeutic targets in HF, but their joint regulatory mechanisms remain poorly understood.
  • Understanding these molecular interactions is crucial for developing effective treatments for HF.

Purpose of the Study:

  • To investigate the mechanisms of microRNA-mRNA joint regulation in heart failure.
  • To identify key genes and pathways involved in ICM and DCM-induced HF.
  • To discover novel diagnostic and therapeutic targets for HF.

Main Methods:

  • Analysis of three gene expression profiles from patients with and without HF.
  • Weighted Gene Co-Expression Network Analysis (WGCNA) to identify key genes in ICM and DCM.
  • MicroRNA-mRNA interaction network analysis and pathway analysis.

Main Results:

  • Shared differentially expressed miRNAs and mRNAs with significant biological functions were identified.
  • The study pinpointed miR-542-3p and its target gene CILP as potentially involved in the TGF-β signaling pathway in ICM-induced HF.
  • A novel mechanism involving miR-542-3p-CILP in the TGF-β signaling pathway was proposed for mediating ICM-induced HF.

Conclusions:

  • The miR-542-3p-CILP interaction within the TGF-β signaling pathway represents a potential novel mechanism in ICM-induced HF.
  • This study provides novel molecular targets for the diagnosis and therapeutic treatment of ICM- and DCM-induced HF.
  • Further research into these identified targets could lead to improved management of heart failure.